Litcius/Paper detail

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer

Li‐Ping Ge, Xi Jin, Ding Ma, Zi-Yu Wang, Chenglin Liu, Chaozheng Zhou, Shen Zhao, Tian‐Jian Yu, Xiyu Liu, Gen-Hong Di, Zhi‐Ming Shao, Yi‐Zhou Jiang

2024Cell Research38 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyCancer researchBreast cancerGene silencingCancerBiologyTriple-negative breast cancerMedicineImmunologyImmune systemGeneGeneticsCancer Genomics and DiagnosticsRNA modifications and cancerImmunotherapy and Immune Responses
ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer | Litcius